Sugi Predict

Sugi Predict / Compounds / SCHEMBL8288256

SCHEMBL8288256

SCHEMBL8288256

SCc1cc(-c2ccc(Cl)cc2)no1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 5/20 0.70
▸ MAPT P10636 4/20 0.58
▸ HTT P42858 3/20 0.58
▸ CYP1A2 P05177 3/20 0.58
▸ CYP2C19 P33261 3/20 0.58
▸ CYP2C9 P11712 2/20 0.58
▸ CYP3A4 P08684 2/20 0.58
▸ CYP2D6 P10635 2/20 0.58
▸ MEN1 O00255 6/20 0.57
▸ KMT2A Q03164 6/20 0.57
▸ SMN1; SMN2 Q16637 6/20 0.57
▸ L3MBTL1 Q9Y468 5/20 0.57
▸ RAB9A P51151 5/20 0.57
▸ NPC1 O15118 4/20 0.57
▸ POLB P06746 1/20 0.56
▸ TDP1 Q9NUW8 2/20 0.55
▸ JAK2 O60674 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ ALPG P10696 1/20 0.55
▸ LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL541967 0.84 NOTUM (0.72) NOTUMMAPTHTTCYP1A2CYP2C19
SCHEMBL3688842 0.82 NOTUM (0.70) NOTUMMAPTHTTCYP1A2CYP2C19
SCHEMBL14541788 0.82 NOTUM (0.70) NOTUMMAPTHTTCYP1A2CYP2C19
SCHEMBL4311207 0.82 NOTUM (1.00) NOTUMMAPTHTTCYP1A2CYP2C19
SCHEMBL2900978 0.82 NOTUM (1.00) NOTUMMAPTHTTCYP1A2CYP2C19
SCHEMBL8288449 0.82 NPC1 (0.54) NOTUMMAPTHTTCYP1A2CYP2C19
SCHEMBL19261295 0.81 NOTUM (0.68) NOTUMMAPTCYP1A2CYP2C19CYP2C9
Ammonia Solution, Strong SCHEMBL28927303 0.81 NOTUM (0.68) NOTUMMAPTHTTCYP1A2CYP2C19
SCHEMBL28927301 0.79 NOTUM (0.76) NOTUMMAPTHTTCYP1A2CYP2C19
SCHEMBL6027760 0.79 NOTUM (0.66) NOTUMMAPTHTTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070281937-A1 Ion Channel Modulators SCION PHARMACEUTICALS, INC. 2007-12-06 — — US disclosed
US-20070203194-A1 Calcium channel modulators comprising 3-thio-4H-1,2,4-triazoles or S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders SCION PHARMACEUTICALS, INC. (US) 2007-08-30 — — US disclosed
US-20070203194-A1 Calcium channel modulators comprising 3-thio-4H-1,2,4-triazoles or S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders SCION PHARMACEUTICALS, INC. (US) 2007-08-30 — — US disclosed
WO-2005087750-A1 ION CHANNEL MODULATORS WYETH (US) 2005-09-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281937-A1 Ion Channel Modulators CACNA1B, CACNA1C, TRPV1 NOTUM 3731/4885MAPT 490/4885HTT 316/4885
US-20070203194-A1 Calcium channel modulators comprising 3-thio-4H-1,2,4-triazoles or S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders CACNA1C, CACNA1D, CACNA1G NOTUM 4473/4885MAPT 427/4885HTT 2081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.